Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2012

Shareholders' Equity

Share-Based Activity

	2012		2011		2010
Share-based compensation expense	$	6,692	$	6,178	$	4,869
Fair value of shares vested		6,425		7,356		1,647
Cash received from option exercises		18,214		6,872		2,583
Tax benefit from option exercises		1,784		977		200

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at January 1, 2010		466,387	$	22.29
	Shares granted	233,460		21.83
	Shares vested	(8,973)		20.45
	Shares forfeited	(25,965)		22.21
Non-vested shares at December 31, 2010		664,909	$	22.16
	Shares granted	276,869		21.78
	Shares vested	(208,949)		23.11
	Shares forfeited	(417)		24.75
Non-vested shares at December 31, 2011		732,412	$	21.91
	Shares granted	281,429		26.78
	Shares vested	(183,019)		25.98
	Shares forfeited	(2,136)		26.26
Non-vested shares at December 31, 2012		828,686	$	22.50

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at January 1, 2010		3,151,052	$	22.22	5.0
	Options exercised with total intrinsic value of $511,000	(157,750)		16.38
	Options terminated	(91,313)		23.73
Outstanding at December 31, 2010		2,901,989	$	22.49	4.5
	Options exercised with total intrinsic value of $2,482,000	(374,350)		18.36
	Options terminated	(17,585)		25.42
Outstanding at December 31, 2011		2,510,054	$	23.09	3.4
	Options exercised with total intrinsic value of $6,287,000	(841,599)		21.64
	Options terminated	(5,625)		21.85
Outstanding at December 31, 2012 with aggregate intrinsic value of $10,289,000		1,662,830	$	23.82	2.9
Vested or expected to vest at December 31, 2012 with total intrinsic value of $10,289,000		1,662,830	$	23.82	2.9
Exercisable at December 31, 2012 with total intrinsic value of $10,289,000		1,662,830	$	23.82	2.9

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

						Per
			Earnings		Shares	Share
			(Numerator)		(Denominator)	Amount
For the year ended December 31, 2012:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	62,585	30,773	$	2.03
	Effect of dilutive securities options and non-vested shares			-	835
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	62,585	31,608	$	1.98
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	62,563	30,773	$	2.03
	Effect of dilutive securities options and non-vested shares			-	835
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	62,563	31,608	$	1.98
For the year ended December 31, 2011:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	50,394	30,452	$	1.65
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	50,394	31,211	$	1.61
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	49,997	30,452	$	1.64
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	49,997	31,211	$	1.60
For the year ended December 31, 2010:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	49,998	30,255	$	1.65
	Effect of dilutive securities options and non-vested shares			-	434
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	49,998	30,689	$	1.63
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	49,825	30,255	$	1.65
	Effect of dilutive securities options and non-vested shares			-	434
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	49,825	30,689	$	1.62